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Trans-SNARE interactions elicit Ca
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a
 
2
 
 
 
 transients trigger many SNARE-dependent mem-
brane fusion events. The homotypic fusion of yeast
vacuoles occurs after a release of lumenal Ca
 
2
 
 
 
.
Here, we show that trans-SNARE interactions promote the
release of Ca
 
2
 
 
 
 from the vacuole lumen. Ypt7p–GTP, the
Sec1p/Munc18-protein Vps33p, and Rho GTPases, all of
which function during docking, are required for Ca
 
2
 
 
 
 release.
Inhibitors of SNARE function prevent Ca
 
2
 
 
 
 release. Recom-
binant Vam7p, a soluble Q-SNARE, stimulates Ca
 
2
 
 
 
 release.
C
 
Vacuoles lacking either of two complementary SNAREs,
Vam3p or Nyv1p, fail to release Ca
 
2
 
 
 
 upon tethering. Mixing
these two vacuole populations together allows Vam3p
and Nyv1p to interact in trans and rescues Ca
 
2
 
 
 
 release.
Sec17/18p promote sustained Ca
 
2
 
 
 
 release by recycling
SNAREs (and perhaps other limiting factors), but are not
required at the release step itself. We conclude that trans-
SNARE assembly events during docking promote Ca
 
2
 
 
 
release from the vacuole lumen.
 
Introduction
 
Conserved molecules govern membrane docking and fusion
in the secretory and endocytic pathways of eukaryotic cells
(Jahn et al., 2003). These molecules include Rab/Ypt
GTPases, Sec17/18p (NSF/
 
 
 
-SNAP) chaperones, Sec1p/
Munc18 (SM) proteins, and SNARE proteins. SNAREs fold
into tight core complexes containing four coiled 
 
 
 
 helices
that are contributed by three or four SNARE proteins
(Sutton et al., 1998; Jahn et al., 2003). SNAREs are categorized
as Q or R, based on whether they contribute a glutamine or
arginine to the ionic (zero) layer of the SNARE core complex
(Fasshauer et al., 1998). Core complexes typically contain
three Q-SNARE coils and an R-SNARE coil. Complementary
SNAREs must be present in trans on docked, apposed
membranes for fusion to occur (Nichols et al., 1997).
Trans-SNARE complexes are hypothesized to assume a
“SNAREpin” structure (Weber et al., 1998; Jahn et al.,
2003) similar to the tetrahelical SNARE core complex, but
with the SNARE transmembrane anchors embedded in
opposite docked membranes. The exact functions of trans-
SNARE complexes are unresolved (Jahn et al., 2003).
Cytosolic Ca
 
2
 
 
 
 is required for many membrane fusion
events. In some cases, ambient [Ca
 
2
 
 
 
] is sufficient for fusion
(Beckers and Balch, 1989; Baker et al., 1990); in other cases,
transient increases in [Ca
 
2
 
 
 
] are needed (Sullivan et al.,
1993; Peters and Mayer, 1998; Chen et al., 1999; Pryor et
al., 2000; Reddy et al., 2001; Rettig and Neher, 2002). In
neurons, depolarization opens voltage-gated Ca
 
2
 
 
 
 channels,
triggering exocytosis (Rettig and Neher, 2002; Jahn et al.,
2003). However, little is known about how Ca
 
2
 
 
 
 regulates
intracellular fusion events such as endosome–endosome fusion.
Even less is known about how Ca
 
2
 
 
 
 signals that regulate in-
tracellular membrane fusion are themselves regulated. Ca
 
2
 
 
 
channels in the plasma membranes of mammalian cells
physically and functionally interact with the Q-SNAREs
syntaxin and SNAP-25 (Bennett et al., 1992; Yoshida et al.,
1992; Sheng et al., 1994; Mochida et al., 1996; Wiser et al.,
1996; Rettig et al., 1997). Ca
 
2
 
 
 
 channels also interact with
the exocytic machinery via the Sec6/8 complex and Rab3-
interacting molecule binding proteins (Shin et al., 2000;
Hibino et al., 2002). On the yeast vacuole, the R-SNARE
Nyv1p inhibits the vacuolar Ca
 
2
 
 
 
 ATPase Pmc1p (Takita et
al., 2001). It is unclear how such interactions are integrated
into cycles of membrane docking and fusion.
Trans interactions between SNARES on opposite mem-
branes have been proposed to facilitate or trigger Ca
 
2
 
 
 
signals in response to docking (Bezprozvanny et al., 1995;
Wiser et al., 1996; Schekman, 1998), but technical obstacles
have precluded direct tests of this hypothesis. The yeast
vacuole offers powerful genetic and biochemical tools that
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allow trans-SNARE interactions to be manipulated in a
physiologically relevant in vitro docking and fusion reaction.
Vacuole fusion begins with priming. In this step, Sec17/18p
(yeast 
 
 
 
-SNAP/NSF) consumes ATP to disassemble cis-
SNARE complexes (Mayer et al., 1996; Ungermann et al.,
1998a). In the next stage, docking, the Rab GTPase Ypt7p
promotes membrane tethering (Mayer and Wickner, 1997;
Ungermann et al., 1998b), and specialized subdomains
called vertex sites assemble at the docking junction (Wang et
al., 2002, 2003). During Ypt7p-mediated docking, Ca
 
2
 
 
 
 is
released from the vacuole lumen (Peters and Mayer, 1998;
Eitzen et al., 2000). This Ca
 
2
 
 
 
 signal is necessary for fusion
because depletion of lumenal Ca
 
2
 
 
 
 makes fusion dependent
on added Ca
 
2
 
 
 
, and chelation of extralumenal Ca
 
2
 
 
 
 with
BAPTA prevents fusion (Peters and Mayer, 1998). We now
show that Ca
 
2
 
 
 
 release during docking occurs in response to
trans-SNARE interactions.
 
Results
 
Vam7p stimulates fusion and reduces its BAPTA sensitivity
 
We were led to explore the roles of SNAREs in Ca
 
2
 
 
 
 flux by
experiments with the soluble Q-SNARE Vam7p. During
priming, Sec17/18p disassembles cis-SNARE complexes.
Vam7p, having neither a hydrophobic transmembrane an-
chor nor a covalently attached lipid anchor, is released from
the membrane during priming (Ungermann and Wickner,
1998; Ungermann et al., 1998a; Boeddinghaus et al., 2002).
For fusion to occur, Vam7p must reassociate with the vacu-
ole membrane via its amino-terminal PX domain, which
binds to phosphatidylinositol-3–phosphate (Cheever et al.,
2001; Boeddinghaus et al., 2002). We found that recombi-
nant Vam7p (rVam7p) promoted fusion in vitro (Fig. 1 A).
This stimulation was more pronounced when recombinant
Sec18p was not added to the reaction (Fig. 1 A), probably
because added Sec18p promotes the release of endogenous
Vam7p from SNARE complexes on the vacuole. Recombi-
nant PX domain prevented Vam7p reassociation (Boedding-
haus et al., 2002) and hence fusion (Fig. 1 B). Anti-Vam7p
antibody (Fig. 1 C) also prevented fusion (Ungermann and
Wickner, 1998; Boeddinghaus et al., 2002). rVam7p re-
versed the PX and anti-Vam7p fusion blocks when added
either at the beginning of the reaction (Fig. 1 D; PX, not
depicted) or 30 min into the reaction, after priming
and during docking (Fig. 1 E; anti-Vam7p, not depicted).
rVam7p did not rescue fusion in reactions inhibited by anti-
bodies against the SNARE Vam3p (Fig. 1, D and E), verify-
ing that rVam7p specifically reverses blockades of Vam7p
function.
Next, we asked whether various inhibitors of fusion (Fig. 1
F) acted before, during, or after the step(s) prevented by PX
domain (Fig. 1 E). Fusion reactions were initiated in the pres-
ence of PX domain and incubated for 30 min to allow prim-
ing and docking, then the PX block was reversed with
rVam7p. During the PX blockade, the reaction passed
through the priming stage, as shown by the acquisition of re-
sistance to anti-Sec17p antibody (Fig. 1 E). Anti-Vam3p an-
tibody, which in kinetic experiments inhibits at docking
(Nichols et al., 1997), inhibited the reaction at high but not
low concentrations (Fig. 1 E). This may indicate that Vam3p
is in an altered conformational or oligomeric state at the end
of the PX block. Strikingly, partial resistance to the Ca
 
2
 
 
 
 che-
lator BAPTA was also observed (Fig. 1 E). This BAPTA resis-
tance was surprising for two reasons. First, although BAPTA
inhibits a late stage in homotypic vacuole fusion, Vam7p was
previously assigned to the intermediate docking stage in ki-
netic assays (Ungermann and Wickner, 1998; Boeddinghaus
et al., 2002). Second, staging experiments had shown that the
vacuole fusion reaction reaches a PX, or anti-Vam7p, resis-
tant state in the presence of BAPTA, suggesting that Vam7p
function is completed before Ca
 
2
 
 
 
 action, not after (Boed-
dinghaus et al., 2002). Two possible explanations for these
apparently divergent results are that the added rVam7p in-
creases the number or sensitivity of Ca
 
2
 
 
 
 sensors, or that it in-
Figure 1. Characterization of rVam7p and Vam7p antagonists. 
(A) Stimulation of fusion by rVam7p. Standard fusion reactions 
(see Materials and methods) were initiated in the presence of 
rVam7p at the indicated concentrations, with or without 10 nM 
of Sec18p. “Ice” indicates fusion signal in a control reaction 
incubated on ice instead of at 27 C. (B) Inhibition of fusion by 
rVam7p PX domain. (C) Inhibition of fusion by affinity-purified 
anti-Vam7p antibody. “Boiled Ab” indicates a sample containing 
anti-Vam7p heat denatured by incubation for 5 min at 100 C. 
(D) rVam7p reverses a fusion block imposed by 150 nM of affinity-
purified anti-Vam7p antibody. “No Ab” indicates control samples 
without antibody. (E and F) Reversal of a PX block by rVam7p and 
characterization of the block. In E, reactions were initiated in the 
presence of 20  M of PX domain and incubated for 30 min at 27 C, 
and the indicated inhibitors were added. 4 min later, 10  M of 
rVam7p was added to reverse the PX block; the reactions were 
incubated at 27 C for an additional 60 min. Reactions moved to 
ice before rescue (ice), or not rescued by rVam7p (no rescue), 
were strongly inhibited by PX domain. In F, the indicated inhibitors 
were added from the beginning of the fusion reaction. Affinity-purified 
anti-Vam3p antibody was added at 58, 115, 230, or 460 nM. 
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creases the frequency or amplitude of Ca
 
2
 
 
 
 efflux events, re-
sulting in reduced BAPTA sensitivity.
 
Docking factors and SNAREs promote Ca
 
2
 
 
 
 release
 
To see if Vam7p influences Ca
 
2
 
 
 
 efflux from the vacuole lu-
men, we used the photoprotein aequorin to monitor the ex-
tralumenal Ca
 
2
 
 
 
 concentration [Ca
 
2
 
 
 
]
 
E
 
 during in vitro
docking and fusion (Peters and Mayer, 1998). We began by
evaluating the importance of proteins that function during
docking.
Vacuoles actively sequester extralumenal Ca
 
2
 
 
 
 during the
first minutes of incubation with ATP (Fig. 2 A, standard).
Experiments with the slow Ca
 
2
 
 
 
 chelator EGTA indicate
that the relatively high initial [Ca
 
2
 
 
 
]
 
E
 
 is due to ambient
Ca
 
2
 
 
 
 present in buffer solutions, and is not necessary for
docking or fusion (Peters and Mayer, 1998; unpublished
data; Margolis, N., personal communication). During dock-
ing, Ca
 
2
 
 
 
 is released from the vacuole lumen into the ex-
tralumenal space, with [Ca
 
2
 
 
 
]
 
E
 
 typically peaking at 30–40
min (Fig. 2 A). As reported previously (Peters and Mayer,
1998), this Ca
 
2
 
 
 
 release requires both Sec17/18p-mediated
priming and Ypt7p-mediated docking. Ca
 
2
 
 
 
 was sequestered
in the vacuole lumen but not released in the presence of
anti-Sec17p antibody (Fig. 1 A). Recombinant Gdi1p
(GDI; GDP dissociation inhibitor [GDI]) or affinity-puri-
fied anti-Ypt7p antibody, both inhibitors of Ypt7p function,
also prevented Ca
 
2
 
 
 
 release (Fig. 2 A).
To determine whether the GTP-bound form of Ypt7p is
needed for Ca
 
2
 
 
 
 release, we used Gyp1–46p and Gyp7–47p,
GTPase activating proteins (GAPs) that promote the hydro-
lysis of Ypt7p-bound GTP (Vollmer et al., 1999; Eitzen et
al., 2000). These GAPs prevent SNAREs and other fusion
factors from accumulating at “vertex” membrane subdo-
mains during docking and prevent fusion (Eitzen et al.,
2000; Wang et al., 2003). Both Gyp1–46p (Fig. 2 B) and
Gyp7–47p (not depicted) prevented Ca
 
2
 
 
 
 release, indicating
a requirement for Ypt7p–GTP. The Rho GTPases Cdc42p
and Rho1p also function during docking (Eitzen et al.,
2001; Muller et al., 2001), possibly by promoting actin re-
modeling on the vacuole membrane (Eitzen et al., 2002).
Rho GDI (RDI) extracts Rho GTPases from membranes
and prevents fusion (Eitzen et al., 2001). RDI prevented
Ca
 
2
 
 
 
 release during docking (Fig. 2 C). The SM protein
Vps33p, a component of the HOPS–class C docking com-
plex (Seals et al., 2000), functions during docking and regu-
lates SNARE complex formation (Price et al., 2000; Sato et
al., 2000). Anti-Vps33p antibody prevented Ca
 
2
 
 
 
 efflux
(Fig. 2 A). Thus docking-dependent Ca
 
2
 
 
 
 release from the
vacuole lumen requires Ypt7p–GTP, vacuolar Rho GTP-
ases, and the SM protein Vps33p.
When rVam7p was added to a standard fusion assay, it
caused an increase in docking-dependent Ca
 
2
 
 
 
 efflux (Fig.
3 A). Ca
 
2
 
 
 
 release was blocked by affinity-purified anti-
Vam7p antibody or PX domain (Fig. 3, A and B). rVam7p
Figure 2. Docking-dependent Ca
2  release depends on Ypt7p–GTP, Rho GTPases, and the SM-protein Vps33p. Standard Ca
2  release reactions 
(see Materials and methods) were initiated in the absence of inhibitors (“standard”; closed circles in each plot) or in the presence of the indicated 
reagents: (A) 380 nM of anti-Sec17p IgG, 2.5  M of GDI, or 100 nM of affinity-purified anti-Vps33p; (B) 50  M of Gyp1–46; (C) 15  M of 
RDI. (A–C) Closed circles denote standard reaction conditions. In A, open squares denote anti-Sec17p; open triangles denote Rab GDI; open 
inverted triangles denote anti-Ypt7p; and open circles denote anti-Vps33p. In B, open circles denote Gyp1-46 treatment. In C, open circles 
denote Rho GDI (RDI) treatment.
Figure 3. SNAREs promote docking-dependent Ca
2  
release. Standard reactions contained: (A) 150 nM of 
affinity-purified anti-Vam7p and/or 10  M of Vam7p; 
(B) 20  M of PX domain and/or 10  M of Vam7p; (C) 120 
nM of affinity-purified anti-Nyv1p or 200 nM of affinity-
purified anti-Vam3p. (D) 1.6  M of affinity-purified 
anti-Vti1p or 120 nM of affinity-purified anti-Nyv1p. 
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reversed the PX and anti-Vam7p blocks (Fig. 3, A and B).
Ca
 
2
 
 
 
 release was also prevented by antibodies against the
Q-SNAREs Vam3p (Fig. 3 C) or Vti1p (Fig. 3 D), or against
the R-SNARE Nyv1p (Fig. 3, C and D). Control IgG, heat-
denatured antibodies, and antibodies against the vacuolar
SNARE Ykt6p had no detectable effect on Ca
 
2
 
 
 
 release un-
der these conditions (unpublished data). Thus the SNAREs
Vam3p, Vti1p, Vam7p, and Nyv1p regulate docking-de-
pendent Ca
 
2
 
 
 
 signaling.
 
Trans-SNARE interactions elicit Ca
 
2
 
 
 
 release
 
Next, we asked whether vacuoles lacking either of two
SNARE proteins would exhibit Ca
 
2
 
 
 
 efflux upon Ypt7p-me-
diated tethering. Vacuoles obtained from cells bearing
 
nyv1
 
 
 
 or 
 
vam3
 
 
 
 null mutations (Fig. 4, B and C) took up
Ca
 
2
 
 
 
 from the extralumenal space but failed to release it. In
reactions containing vacuoles that lacked either Nyv1p or
Vam3p, [Ca
 
2
 
 
 
]
 
E
 
 was unresponsive to recombinant Gdi1p
(Fig. 4, B and C) or anti-Ypt7p antibody (not depicted).
Similarly, these SNARE-deficient vacuoles were unrespon-
sive to antibodies against Vam3p, Nyv1p (Fig. 4, B and C)
or Vam7p (not depicted). Both Nyv1p and Vam3p-defi-
cient vacuoles undergo Ypt7p-dependent tethering (Unger-
mann et al., 1998b; Wang et al., 2003). The severe Ca
 
2
 
 
 
release defects exhibited by these vacuoles shows that mem-
brane tethering, without a full complement of SNAREs, is
not sufficient to trigger Ca
 
2
 
 
 
 release.
Vam3p and Nyv1p can promote fusion from opposite
membranes, i.e., in trans (Nichols et al., 1997; Ungermann
et al., 1998b). Vacuoles lacking Vam3p do not fuse with
vacuoles lacking Vam3p, and vacuoles lacking Nyv1p do not
fuse with vacuoles lacking Nyv1p. However, vacuoles lack-
ing Vam3p do fuse with vacuoles lacking Nyv1p, indicating
that these Q- and R-SNAREs functionally interact in trans
(Nichols et al., 1997; Ungermann et al., 1998b). We there-
fore asked whether docking-dependent Ca
 
2
 
 
 
 flux is also re-
stored by the mixture of Vam3p- and Nyv1p-deficient vacu-
oles. As shown in Fig. 4 D, this was indeed the case. Ca
 
2
 
 
 
release by the vacuole mixture was docking-dependent be-
cause it was prevented by GDI blockade of Ypt7p function.
Ca
 
2
 
 
 
 release by mixtures of vacuoles from 
 
vam3  and
nyv1  cells is blocked by antibodies against Vam3p or
Nyv1p (Fig. 4 D). Thus, functional trans interactions be-
tween Q- and R-SNAREs trigger docking-dependent Ca
2 
release from the vacuole lumen.
Cycles of trans-SNARE complex assembly promote 
Ca
2  release
Sec17/18p disassemble complexed SNARE proteins. Re-
combinant Sec17p and Sec18p, and antibodies against these
proteins, have provided useful tools for the manipulation of
SNARE assembly dynamics. To further test whether the oli-
gomeric state of SNARE proteins regulates Ca
2  release, we
tested the effect of recombinant Sec18p (Fig. 5 A). Sec18p
stimulated Ca
2  release at up to 300 nM; at higher concen-
trations this stimulation declined (see Discussion). The
stimulatory effect of rVam7p and Sec18p (Fig. 5 A) com-
bined was greater than with either reagent alone.
Next, we asked whether the effect of Sec17/18p was con-
fined to the early, priming phase of the reaction. Standard
reactions were started, and various reagents were added to
the reactions at  18 min, after priming (Mayer et al., 1996;
Ungermann et al., 1998a) and during the normal docking-
dependent Ca
2  efflux (Fig. 5 B). Recombinant Sec18p
caused an immediate increase in the amplitude of Ca
2  ef-
flux (compare high Sec18p to standard), suggesting that
Sec18p regulates the amplitude of Ca
2  release during dock-
ing. Anti-Sec17p antibodies added either alone or immedi-
ately before recombinant Sec18p caused a rapid attenuation
of Ca
2  release (Fig. 5 B). Therefore, the stimulatory effect
of recombinant Sec18p depends on endogenous Sec17p.
When added in excess over endogenous Sec18p, recom-
binant Sec17p inhibits fusion, by recapturing unpaired
SNAREs into cis complexes (Wang et al., 2000). This inhi-
bition of fusion can be reversed by the addition of stoichio-
metric amounts of Sec18p. Excess Sec17p added at  18
min inhibited Ca
2  release (Fig. 5 B), and recombinant
Sec18p reversed this inhibition. Sec18p-mediated stimula-
tion of Ca
2  efflux is abolished by anti-Vam3p antibody
(unpublished data), indicating a SNARE requirement. Pre-
vious work in our laboratory (Mayer et al., 1996; Unger-
mann et al., 1998a) showed that anti-Sec17p or anti-Sec18p
antibodies added after  15 min have little effect on fusion,
indicating that Sec17/18p function early (during priming)
Figure 4. Trans-SNARE interactions elicit docking-
dependent Ca
2  release. The data plotted in A–D are 
from the same assay. Standard reactions contained: 
(A) 10  g (protein content) of vacuoles derived from 
the parental strain BJ3505; (B) 10  g of vacuoles from 
an nyv1  derivative of BJ3505; (C) 10  g of vacuoles 
from a vam3  derivative of BJ3505; (D) a mixture of 5  g 
each of vacuoles from the vam3  and nyv1  strains. 
Symbols: closed circles, standard reaction conditions; 
open circles, reactions with recombinant GDI; triangles, 
reactions with anti-Vam3p antibody; inverted triangles, 
reactions with anti-Nyv1p antibody. Inhibitor concen-
trations are as in Fig. 1. With Nyv1p-deficient vacuoles, 
a small but reproducible decrease in [Ca
2 ]E was observed 
in the presence of docking inhibitors or anti-SNARE 
antibodies. This residual docking-dependent Ca
2  release 
( 5% of that seen with vacuoles from wild-type cells) 
may be mediated by R-SNAREs other than Nyv1p.Ca
2  and SNAREs | Merz and Wickner 199
in a standard fusion reaction. Under the conditions used to
measure Ca
2  release similar results were obtained, with fu-
sion inhibited by less than 30% when antibodies were added
at 15–18 min. The observation that Sec17/18p regulate
Ca
2  release even after 15 min (during docking) raised the
question of whether Sec17/18p act during the Ca
2  release
step itself or act indirectly, by promoting the availability of
unpaired SNAREs or SNARE associated factors such as the
HOPS–class C complex.
To see if Sec17/18p action and Ca
2  release could be un-
coupled, we used an antipeptide antibody that permits re-
versible inhibition of the Ypt7p GTPase. Ypt7p block-rever-
sal can be used to allow Sec17/18p-mediated priming while
accumulating the vacuoles at an early, Ypt7p-dependent
stage of docking. Relief of the anti-Ypt7p block by adding
the antigenic peptide allows the vacuoles to proceed through
docking and fusion in a relatively synchronous manner
(Eitzen et al., 2001, 2002). Reactions were initiated either
Figure 5. Docking-dependent Ca
2  release is stimulated 
by Sec17/18p. (A) Simulation of Ca
2  release by Sec18p. 
(B) Sec17/18p promote ongoing Ca
2  release. Standard 
reactions were initiated, and at 18 min, the microplate 
was removed from the luminometer, and additional 
reagents were added: 200 nM of high Sec18p; 150 nM 
of high Sec17p; and 380 nM of anti-Sec17p or anti-Sec18p 
IgG. Anti-Sec17/18p antibodies were also added from the 
reaction start to two samples, as indicated on the plot.
Figure 6. Docking-dependent Ca
2  release without 
ongoing Sec17/18p action. Standard reactions 
were initiated in the presence of affinity-purified 
anti-Ypt7p peptide antibody and incubated at 
26 C. At 30 min, the reactions were moved to ice, 
second inhibitors (antibodies against SNAREs or 
Sec17p) were added as indicated on the plot, 
and the anti-Ypt7p block was reversed by addition 
of excess Ypt7p peptide. No peptide was added 
to the “no rescue” sample. The samples were then 
assayed for Ca
2  release at 26 C.200 The Journal of Cell Biology | Volume 164, Number 2, 2004
without or with the Ypt7p antibody (Fig. 6). In reactions
blocked with anti-Ypt7p for 35 min and then reversed (Fig.
6), anti-SNARE antibodies added 5 min before reversal were
still inhibitory, indicating that SNARE function is still
needed after priming, and during or after Ypt7p function. In
marked contrast, anti-Sec17p antibodies did not prevent
Ca
2  release upon peptide rescue. In a control reaction, anti-
Sec17p, when added from the start of a reaction without
anti-Ypt7p, prevented Ca
2  release. Thus, Sec17/18p func-
tion is not required during Ca
2  release step itself.
We observed consistently that Ca
2  release upon reversal
of a Ypt7p block decayed more rapidly in the presence than
in the absence of anti-Sec17p antibody (Fig. 6). This result,
along with the results shown in Fig. 5 B, suggests that
Sec17/18p promotes sustained Ca
2  signaling by promoting
cycles of SNARE complex disassembly and trans-complex
formation. To test the idea that Sec17/18p can promote sus-
tained Ca
2  release by stimulating SNARE complex turn-
over and thereby increasing the frequency of trans-SNARE
interactions, we used three different block-reversal protocols
to examine the kinetics of Ca
2  efflux (Fig. 7 A). In each
case, the block was maintained for 20 min before reversal.
First, priming was blocked with anti-Sec18p antibody and
reversed with recombinant Sec18p (Fig. 7 A, trace a). Ca
2 
efflux was observed with kinetics similar to those seen in the
standard reaction, with an additional delay corresponding to
the block.
Second, we took advantage of recent observations that,
under appropriate conditions, rVam7p can bypass the re-
quirement for Sec17/18p-mediated priming (unpublished
data; Thorngren, N., personal communication). It appears
that the only essential event mediated by Sec17/18p in vitro
is the liberation of Vam7p from cis-SNARE complexes; suf-
ficient quantities of unpaired integral-membrane SNAREs
are present on unprimed vacuoles to catalyze fusion when
the reaction is supplemented with rVam7p. When rVam7p
was added to an anti-Sec17p-blocked reaction (Fig. 7 A,
trace b), a fast spike of Ca
2  release was observed and this
spike rapidly decayed. Similar results were obtained when
rVam7p was used to bypass an anti-Sec18p block (unpub-
lished data). We also asked if rVam7p could interact with
Vam3p and Nyv1p located in trans to one another to pro-
mote efflux. For this purpose, a complementation ex-
periment similar to the one shown in Fig. 3 was used. We
Figure 7. Sec17/18p promote sustained Ca
2  efflux. 
(A) Kinetics of Ca
2  release in three block/rescue protocols. 
Blocks were imposed in standard reactions for 20 min 
before rescue: trace a, anti-Sec18p block/Sec18p reversal; 
trace b, anti-Sec17p block/rVam7p reversal; trace c, PX 
block/rVam7p reversal. IgG against Sec17p and Sec18p 
were used at 380 nM, PX was used at 20  M, and rVam7p 
was used at 10  M. The dotted line shows the arithmetic 
mean of traces a and b. (B) Reactions containing SNARE-
deficient vacuoles were initiated in the presence of 
anti-Sec17p, incubated for 20 min, and rescued with the 
indicated amounts of rVam7p. Control reactions not 
rescued with rVam7p (not depicted) did not exhibit Ca
2  
efflux, similar to reactions containing both anti-Vam3p 
antibody and rVam7p.Ca
2  and SNAREs | Merz and Wickner 201
found that rVam7p elicited transient Ca
2  efflux from anti-
Sec17p-blocked mixtures of vacuoles derived from vam3 
and nyv1  cells (Fig. 7 B), but it did not elicit Ca
2  efflux
from either population alone. Anti-Vam3p antibody com-
pletely suppressed rVam7p rescue (Fig. 7 B). rVam7p bypass
of an anti-Sec17p block thus requires Vam3p and Nyv1p,
even when these SNAREs are available only in trans and not
in cis. These results suggest that on pretethered vacuoles,
rVam7 promotes near-synchronous formation of many
trans-SNARE complexes and rapid Ca
2  efflux. In the ab-
sence of Sec17/18p activity, rVam7p-elicited efflux is short-
lived relative to the sustained release promoted by Sec17/
18p (Fig. 7 A, compare trace a with trace b).
In the third block-reversal protocol, PX domain was used
to block Vam7p reassociation, and rVam7p was used to re-
verse the PX block as in Fig. 1 F. Under a PX block, priming
and Ypt7p-dependent docking occur, but vertex assembly is
incomplete and trans-SNARE pairing is prevented (Boed-
dinghaus et al., 2002; Wang et al., 2003). When the PX
block was reversed, an immediate Ca
2  spike was observed
(Fig. 7 A, trace c), and this spike was followed by prolonged
Ca
2  release. When we plot the average values of the imme-
diate spike from the anti-Sec17p/rVam7p reversal (Fig. 7 A,
trace b) and the sustained but delayed spike from the anti-
Sec18p/Sec18p reversal (Fig. 7 A, trace a), we obtain a curve
(Fig. 7 A, dashed line) that closely matches the rescue curve
for PX/rVam7p reversal. In addition, when the PX block
was reversed by rVam7p in the presence of anti-Sec17p, the
sustained component of the Ca
2  flux was absent and only
the spike was observed as in trace b (unpublished data). To-
gether, these experiments show that the reversal of inhibitor
blocks by rVam7p can be used to synchronize Ca
2  release,
and confirm that Sec17/18p promotes sustained cycles of
Ca
2  release but need not operate during a single Ca
2 
release event. We conclude that Sec17/18p disassembles
SNARE complexes, producing unpaired SNAREs, which in
turn enter new trans complexes that elicit Ca
2  release.
Under standard in vitro conditions (Conradt et al.,
1994; Wang et al., 2002), two to three rounds of fusion
occur in 60–90 min (unpublished data). Because of the
prompt onset and decay of Ca
2  release when rVam7p was
used to reverse an anti-Sec17p block, we asked if fusion
was accelerated under these conditions. Three approaches
were used. First, we used anti-Vam3p antibody to block
docking at various times after reversal (Fig. 8 A). Within 2
min after reversal, the shortest time tested, fusion had be-
come completely resistant to anti-Vam3p. In contrast,
when anti-Vam3p was added immediately before rVam7p,
no fusion was observed. Thus, Vam3p is required at the
time of rVam7p addition, but it is needed (or its functional
determinants are antibody accessible) for  2 min after
rVam7p addition. To examine fusion more directly, we
measured vacuole size (surface area) under four conditions:
at 1–4 min after Vam7p reversal of anti-Sec17p; at 20–25
min after reversal; in reactions that were blocked but not
reversed; and in reactions not blocked with anti-Sec17p
(Fig. 8 B). We found that the geometric mean surface area
of the vacuoles increased by 54% within 4 min after
rVam7p reversal of the anti-Sec17 block, but no additional
size increase was detected at later times. This methodology
underestimates the actual amount of fusion because some
limiting membrane is lost into the lumen in most fusion
events (Wang et al., 2002), and because vacuoles too small
to resolve ( 250-nm diam) likely fuse to form small vacu-
oles that are then resolved, lowering the population’s mea-
sured size. Thus, at least 0.5 round of fusion occurred in
the experiment shown, a result consistent with the amount
of alkaline phosphatase maturation observed in our stan-
dard fusion assay (unpublished data). In the third ap-
proach, we observed fusion in real time during the 1–4
min interval (Video 1, available at http://www.jcb.org/cgi/
content/full/jcb.200310105/DC1). During this interval,
we observed fusion among  15% of the vacuoles. This
measurement also is likely to underestimate fusion because
recording was initiated  1 min after reversal of the block
by rVam7p, and because events out of the focal plane
could not be clearly resolved. Thus, docking (assayed by
sensitivity to anti-Vam3p), Ca
2  efflux, and fusion occur
promptly upon rVam7p-mediated bypass of the priming
block. Together, our data show that the forward pathway
of trans-SNARE complex assembly leads to Ca
2  release
and fusion. Sec17/18p are not needed during Ca
2  efflux
Figure 8. Fusion triggered by rVam7p. (A) Kinetic window 
of anti-Vam3p sensitivity. Standard reactions were initi-
ated in the presence of anti-Sec17p or anti-Sec18p IgG, 
incubated for 20 min at 27 C, and rescued with either 
Sec18p or Vam7p. At the indicated times after reversal 
anti-Vam3p antibody was added to the reactions. Fusion 
signals are normalized by subtracting the corresponding 
no-rescue signals. (B) Fusion occurs promptly upon 
Vam7p rescue of an anti-Sec17p block. Standard reactions 
were blocked or not blocked with anti-Sec17p as in A. 
Blocked reactions were rescued with Vam7p. Vacuoles 
were photographed at the times indicated after rescue, 
and membrane surface areas were calculated from vacuole 
diameters (see Materials and methods). Bars indicate 
geometric mean surface areas with 95% confidence 
intervals. Asterisks denote pairs of treatments that differ 
at P   0.001 by the Wilcoxon test. B summarizes data 
pooled from two independent experiments that yielded 
similar results when analyzed separately.202 The Journal of Cell Biology | Volume 164, Number 2, 2004
but promote sustained Ca
2  efflux by catalyzing SNARE
complex turnover and making unpaired SNAREs available
for additional cycles of trans-complex assembly.
Docking-dependent Ca
2  release occurs through 
a novel pathway
To further characterize the nature of docking-dependent
Ca
2  release, we tested vacuoles derived from several mu-
tants with defects in Ca
2  transport. Deletion of the genes
encoding each of the three known Ca
2  channel subunits
in budding yeast, Cch1p, Mid1p (Fig. 9, A and B), and
Yvc1p (not depicted), did not substantially change dock-
ing-dependent Ca
2  release. Pmc1p encodes a vacuolar
Ca
2  ATPase that binds and is regulated by the R-SNARE
Nyv1p (Takita et al., 2001), suggesting that it might be
involved in SNARE-mediated Ca
2  fluxes. Vacuoles from
pmc1  cells indeed sequestered Ca
2  slowly, resulting in a
“resting” Ca
2  level elevated by  200 nM when docking
was prevented (Fig. 9 A). However, when docking was al-
lowed to proceed a docking-dependent Ca
2  efflux of nor-
mal amplitude was observed (Fig. 9 B). These results sug-
gest that Pmc1p is not needed for docking-dependent
Ca
2  efflux. However, it is possible that the docking-
dependent flux occurs both through SNARE-mediated
inactivation of Pmc1p and opening of a channel. There-
fore, we constructed double mutants containing the
pmc1  allele in combination with cch1  or mid1  alleles.
Vacuoles from each of these double mutant strains exhib-
ited Ca
2  sequestration and efflux phenotypes similar to
the pmc1  single mutant (Fig. 9, A and B). These results
suggest that docking-dependent Ca
2  release from the
vacuole occurs through a novel pathway.
Discussion
SNARE dynamics and Ca
2  release
A working model of SNARE dynamics and Ca
2  function is
shown in Fig. 10. Under standard in vitro fusion conditions,
Sec18/18p-mediated priming (Fig. 10 A) disassembles cis-
SNARE complexes, yielding unpaired SNAREs on the
membrane and causing the release of endogenous Vam7p.
Docking (Fig. 10 B) entails several steps. Membrane tether-
ing is regulated by the GTPase Ypt7p (Mayer and Wickner,
1997), which also marks the locations where vertex subdo-
mains will be assembled. Vertex assembly is a hierarchical
process that results in the local enrichment of many fusion-
related factors, phosphoinositides and ergosterol (unpub-
lished data; Fratti, R., personal communication), actin, the
HOPS-tethering complex, which includes the SM-protein
Vps33p, and SNAREs (Wang et al., 2002, 2003). Vertex as-
sembly may promote trans-SNARE interactions, which di-
rectly or indirectly trigger transient Ca
2  release events. In-
creases in [Ca
2 ]E in turn promote downstream events (Fig.
10 C) that lead to fusion. Fusion initiates at vertex sites
(Wang et al., 2002); we speculate that both trans-SNARE
pairing and focal Ca
2  release occur at the vertex. rVam7p
bypasses the requirement for in vitro Sec17/18p-mediated
priming. When added to tethered vacuoles, Vam7p causes a
rapid, transient spike of Ca
2  release and fusion. Sustained
Ca
2  release and fusion require ongoing Sec17/18p function
for a continuing supply of unpaired SNAREs.
Trans-SNARE interactions promote Ca
2  release
Our experiments with antibodies, rVam7, PX domain, and
vacuoles isolated from SNARE-deficient mutants implicate
four vacuolar SNARE proteins in docking-dependent Ca
2 
release: the Q-SNAREs Vam7p, Vam3p, and Vti1p; and
the R-SNARE, Nyv1p. Antibodies against Ykt6p, a fifth
SNARE found in vacuolar cis-complexes (Ungermann et al.,
1999), did not inhibit Ca
2  release. As each of these
SNAREs could contribute one coil to a tetrahelical “core
complex” (Sutton et al., 1998), the requirement for all four
is consistent with the hypothesis that tetrahelical trans-
SNARE complexes regulate Ca
2  release.
Trans-SNARE interactions can occur only during dock-
ing. If Ca
2  release is triggered by trans-SNARE interac-
tions, then docking-independent SNARE complex assembly
and disassembly should not cause Ca
2  release. Consistent
with this prediction, staging experiments show that SNAREs
are needed for Ca
2  release at a post-priming step of the re-
action (Figs. 6 and 7). Moreover, the addition of excess
recombinant Sec17p, which inhibits fusion by promoting
the reformation of cis-SNARE complexes from unpaired
SNAREs, attenuates Ca
2  release (Fig. 4 C), indicating that
cis-SNARE complex reformation does not trigger Ca
2  re-
lease. Together, these results indicate that neither cis-
SNARE complex disassembly nor cis-complex reformation
trigger Ca
2  release.
Ypt7p is required for tethering, vertex assembly, and
trans-SNARE pairing (Mayer and Wickner, 1997; Unger-
mann et al., 1998b; Wang et al., 2002, 2003). As shown in
Fig. 5, SNAREs are needed for Ca
2  release at a stage during
or after Ypt7p function, for example, during docking. In ad-
Figure 9. SNARE-regulated Ca
2  release from vacuoles lacking 
Ca
2  transporters. Vacuoles isolated from wild-type strain BY4742 or 
the indicated isogenic mutant strains (see Materials and methods) were 
assayed for Ca
2  release in the presence (A) or absence (B) of anti-
Vam3p IgG. Reactions were under standard conditions (see Materials 
and methods) except that 250 nM rVam7p was added in all cases. The 
variability among the traces in B is comparable to that seen from day to 
day among independent vacuole preparations from a single strain.Ca
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dition, Rho GTPases and the SM-protein Vps33p act at
docking, regulate SNARE complex formation (Sato et al.,
2000; Eitzen et al., 2001; Muller et al., 2001), and are
needed for Ca
2  release.
The most direct evidence that trans-SNARE interactions
trigger Ca
2  release is shown in Fig. 4: in vitro comple-
mentation between populations of vacuoles lacking either
Vam3p or Nyv1p indicates that these SNAREs can act from
opposite membranes to trigger docking-dependent Ca
2  re-
lease. Moreover, rVam7p stimulation of Ca
2  release re-
quires both Vam3p and Nyv1p, even when these SNAREs
are located in trans to one another (Fig. 7 B).
Role of Sec17/18p
Two types of staging experiments, Ypt7p block release and
Vam7p bypass of Sec17/18p function, indicate that Sec17/
18p need not function during the Ca
2  release event itself.
Instead, Sec17/18p are required for sustained cycles of Ca
2 
release, as shown in Fig. 5 B, Fig. 6 B, and Fig. 7 A. Sec17/
18p catalyze the disassembly of SNARE complexes, liberat-
ing unpaired SNAREs which can participate in new trans in-
teractions. Recombinant Sec18p promotes Ca
2  release with
maximal stimulation at  300 nM (Fig. 5 A), close to the in
vivo level of  200 nM (Ghaemmaghami et al., 2003). At
higher levels of Sec18p ( 400 nM), the stimulation of Ca
2 
release is attenuated, possibly due to the disassembly of
trans-SNARE complexes (Ungermann et al., 1998b) before
they can complete their stimulation of Ca
2  efflux. When
Sec17/18p function is prevented, Ca
2  release decays rap-
idly. These observations suggest that each trans-SNARE in-
teraction event triggers only a short-lived transient of Ca
2 
release, and that repeated cycles of trans-SNARE interac-
tions are needed for sustained Ca
2  release.
The Ca
2  release pathway
Our data show that docking-dependent trans-SNARE inter-
actions promote Ca
2  release. However, we emphasize that
the functional trans-SNARE interactions defined in this pa-
per might not be identical to SNARE core complexes or
trans-SNARE complexes isolated from vacuole detergent ex-
tracts (Ungermann et al., 1998b); additional work is needed
to understand SNARE association cycles and dynamics.
Docking-dependent Ca
2  release may be triggered directly
by SNARE interactions with a Ca
2 -releasing channel, or re-
lease may result from sequential interactions of SNAREs on
apposed membranes with unidentified intermediary mole-
cules.
It is unlikely that the observed Ca
2  release occurs as an
indirect consequence of fusion events. Mayer’s group re-
cently reported that vacuoles isolated from vph1  cells dock
and release Ca
2  in a Ypt7p-dependent manner, but do not
go on to fuse (Bayer et al., 2003). In addition, manipulation
of Sec17/18p function after priming can dramatically raise
or lower the amplitude of Ca
2  release with only modest ef-
fects on fusion. These observations, together with the Ca
2 -
dependence of fusion itself (Peters and Mayer, 1998),
strongly suggest that the Ca
2  release events studied here oc-
cur during docking, not after fusion.
A channel or transporter required for docking-dependent
Ca
2  release from the vacuole has not yet been identified,
despite our efforts (Fig. 8) and studies of vacuolar Ca
2  ho-
meostasis in other laboratories (Takita et al., 2001; Bayer et
al., 2003; Zhou et al., 2003). A number of uncharacterized
ORFs in S. cerevisiae appear to encode ion transporters, and
one of these could be responsible for docking-dependent
Ca
2  release. However, redundancy among more than one
transporter might frustrate efforts to identify the relevant
proteins through analyses of single knockouts.
Docking-dependent Ca
2  release might occur through less
conventional mechanisms. In most models of fusion, lipids
at the fusion site transiently assume nonbilayer morpholo-
gies. Simulations (Muller et al., 2003) indicate that these re-
arrangements may form transient pores between cytoplasmic
and noncytoplasmic compartments, and careful measure-
ments of fusion events mediated by the influenza hemagglu-
tinin protein confirm that transient leakage currents can
accompany fusion (Frolov et al., 2003). Trans-SNARE
complex formation might directly promote ion flux by per-
turbing bilayer structure.
Implications of SNARE-dependent Ca
2  release 
during docking
The physical proximity of Ca
2  channels to the fusion ma-
chinery is suggested by experiments in which fusion is pre-
vented by fast, but not slow, Ca
2  chelators (Sullivan et al.,
1993; Neher, 1998; Peters and Mayer, 1998; Pryor et al.,
2000), and by the brief interval ( 200  s) between channel
gating and exocytosis in neurons (Llinas et al., 1981). Fur-
thermore, many reports document physical and regulatory
interactions between Ca
2  channels and SNARE proteins in
animal cells (Bennett et al., 1992; Yoshida et al., 1992;
Sheng et al., 1994; Mochida et al., 1996; Wiser et al., 1996;
Rettig et al., 1997). Ca
2  channels associate with other fu-
sion factors, including Rab3-interactor binding proteins
(Hibino et al., 2002) and the synaptic Ca
2  sensor synap-
totagmin (Sudhof, 2002). SNAREs are also implicated in
store-operated Ca
2  entry, which may require membrane
docking (Yao et al., 1999). Interactions between Ca
2  sig-
naling proteins and docking and fusion factors could have
two functions: to allow channels to monitor the functional
Figure 10. Current working model of SNARE and Ca
2  dynamics 
on the yeast vacuole. See text for discussion.204 The Journal of Cell Biology | Volume 164, Number 2, 2004
status of docking over time, and to ensure that the fusion
machinery and regions of peak Ca
2  flux coincide in space
(Neher, 1998). For intracellular fusion events, these interac-
tions may trigger Ca
2  flux in response to successful dock-
ing. In synapses, where voltage-gated Ca
2  channels respond
to membrane depolarization, similar mechanisms might bias
Ca
2  flux toward channels associated with primed and
docked vesicles. Our experiments with vacuoles suggest that
trans-SNARE complex formation is a checkpoint that con-
trols progression to fusion. In this view, trans-SNARE inter-
actions signify that docked membranes reside within a cer-
tain minimum distance and verify that specific biochemical
events have transpired (e.g., priming and vertex subdomain
assembly), triggering Ca
2  release and downstream events
leading to fusion.
Materials and methods
Yeast strains
The standard strains used in our assays are BJ3505 (MAT  pep4::HIS3
prb1- 1.6R his3–200 lys2–801 trp1- 101 [gal3] ura3–52 gal2 can1;
Jones, 2002) and DKY6281 (MAT  leu2–3 leu2–112 ura3–52 his3- 200
trp1- 901 lys2–801; Haas et al., 1994). vam3  and nyv1  derivatives of
BJ3505 and DKY 6281 were prepared as described previously (Nichols et
al., 1997). BY4742 (MAT  his3 1 leu2 0 lys2 0 ura3 0; Brachmann et
al., 1998), BY4742 yvc1 ::neo, BY4742 cch1 ::neo, and BY4742 mid1 ::
neo were obtained from Research Genetics. BY4742 and its derivatives
were used to generate AMY10 (  BY4742 pmc1 ::LEU2), AMY11 ( 
BY4742 cch1 ::neo pmc1 ::LEU2), and AMY12 (  BY4742 mid1 ::neo
pmc1 ::LEU2) by transformation with HindIII-cut pKC52 (Cunningham
and Fink, 1994) and selection on CSM lacking Trp. The double mutant
strains AMY11 and AMY12 grew well on YPD medium (Difco) and had
similar growth defects as the pmc1  single mutant AMY10 on YPD me-
dium with 0.2 M Ca
2 .
Reagents
rVam7p (residues 2–316) and Vam7p PX domain (residues 2–123) were
expressed as GST fusions from the pGEX-KT vector (Hakes and Dixon,
1992) in BL21-pRP cells (Stratagene). VAM7 sequences were amplified
from BJ3505 DNA using a forward primer with an engineered BamH1 site
(5 -cgcGGATCCGCAgctaattctgtaggg-3 ) and reverse primers with engi-
neered EcoR1 sites (5 -cgGAATTCTCAagcactgttgttaaaatgtctagc-3  for
rVam7p, and 5 -cgGAATTCACTTtgacaactgcaggaagac-3  for PX). Cells
were grown in TB medium (Maniatis et al., 2001), 200 mg/l ampicillin, and
34 mg/l chloramphenicol to OD600   2.3, and expression was induced
with 0.5 mM IPTG for 4 h at 26 C. Cell pellets (10,000 g, 20 C, 5 min)
were resuspended in two pellet volumes of PBS with 2 mM EGTA, 1 mM
EDTA, 1  protease inhibitor cocktail (Haas, 1995), 1 mM PMSF, and
0.01% 2-mercaptoethanol. The cell suspension was frozen dropwise in
liquid N2 and stored at –80 C. Cells were thawed, lysed in a French press,
mixed with Triton X-100 (0.5% final), and rocked for 20 min at 4 C before
clearing (20,000 g, 4 C, 30 min). Glutathione-agarose (1 ml of slurry per
10 ml of lysate; Amersham Biosciences) was added to cleared lysate and
rocked overnight at 4 C. The beads were washed with PBS supplemented
as above (20 bed volumes), then with PBS alone (20 bed volumes), and fi-
nally with cleavage buffer (50 mM TrisCl, pH 8.0, 100 mM NaCl, 2 mM
CaCl2, 0.1% 2-mercaptoethanol; 10 bed volumes). Proteins were cleaved
from the support with thrombin ( 10 U/mg fusion protein, in two to three
bed volumes of cleavage buffer; Sigma-Aldrich) for 3–4 h at 23 C. Throm-
bin was removed by flowing the eluted cleavage products directly over a
second column containing 1 ml p-aminobenzamidine–agarose (Sigma-
Aldrich). Proteins were exchanged into reaction buffer (20 mM PIPES/
KOH, pH 6.8, 125 mM KCl, 5 mM MgCl2, 200 mM sorbitol) on G-25 resin
(Amersham Biosciences). Aliquots were frozen in liquid N2, stored at
–80 C, and thawed just before use.
Antibodies were raised against peptides from Ypt7p (Eitzen et al., 2001),
Vps33p (for Vps33p, NH2-CLEDTEQWQKDGFDLNSKKT, and NH2-CIE-
DEHAADKITNENDDFSEA); against rVam7p and Sec17p (Haas and Wick-
ner, 1996); and against recombinant cytoplasmic domains of Vam3p
(Nichols et al., 1997), Nyv1p (Ungermann et al., 1998a), and Vti1p (Un-
germann et al., 1999). IgG or affinity-purified antibodies were prepared as
described previously (Harlow and Lane, 1999). For anti-Ypt7p reversal
(Eitzen et al., 2001) peptide was used at 20  g/ml final. Antibodies were
stored in PS buffer (20 mM Pipes/KOH, 200 mM sorbitol, pH 6.8) at 4 C or
–80 C after buffer exchange on Sepharose G-25 resin (Amersham Bio-
sciences) or dialysis. Some antibody preparations were concentrated in
Microcon-30 ultrafiltration devices (Millipore).
Fusion
30  l of standard fusion reactions contained a 1:1 mixture of vacuoles
(Haas, 1995) from strains BJ3505 and DKY6281 (6  g total protein by
Bradford assay; premixed in PS buffer) added to a mixture containing: 20
mM Pipes/KOH, pH 6.8, 200 mM sorbitol, 125 mM KCl, 5 mM MgCl2, 10
 M coenzyme A, 4.5  M recombinant Pbi2p (IB2), 10 nM recombinant
His6-Sec18p (except as noted), 1% (wt/vol) defatted BSA (Sigma-Aldrich),
and 0.03  protease inhibitor cocktail (Haas, 1995). ATP-regenerating sys-
tem (Haas, 1995) was added from a 10  stock to 1  final (0.67  for Ca
2 
efflux assays). Fusion assays were incubated for 80 min at 27 C or as noted
in figure legends, and fusion was measured by determining the amount of
active alkaline phosphatase as described previously (Haas, 1995) except
that phosphatase assay buffer was supplemented with 10 mM CaCl2. Ca
2 
efflux assays were performed with 10  g rather than 6  g of vacuoles per
30  l vol. For experiments using vacuoles from mutant cells, highly pure
oxalyticase (Enzogenetics) was used to prepare spheroplasts for vacuole
isolation.
Ca
2  assay
Aequorin luminescence assays were performed as described previously
(Peters and Mayer, 1998; Muller et al., 2002) with modifications. Samples
were analyzed in 96-well, low protein binding, conical bottom plates
(Nunc) in a luminometer (Molecular Devices). IGOR Pro 4 (WaveMetrics)
and JMP 5 (SAS Institute) were used for data analysis. Calibration was done
using buffered Ca
2  EGTA standard solutions containing reaction salts in-
cluding the ATP regenerating system, prepared as described previously
(Tsien and Pozzan, 1989), and checked with MAX Chelator (Bers et al.,
1994) version WEBMAXC 10.14.2002 (http://www.stanford.edu/~cpatton).
Commercial Ca
2  standards gave similar results. A curve was fit to the lu-
minance for each Ca
2  standard divided by peak luminance at saturating
Ca
2  (L/Lmax), using a two-state model with three Ca
2 -binding sites (Allen
et al., 1977): L/Lmax   [(1   KR [Ca
2 ])/(1   KTR   KR [Ca
2 ])]
3.
We obtained KR   3.88   0.88   10
6 M
 1 and KTR   1.45   0.29  
10
2 (mean   SD) similar to values reported by Allen et al. (1977). KR and
KTR were used to calculate [Ca
2 ] in experimental samples. In addition to
Ca
2 -dependent luminance, aequorin undergoes irreversible, Ca
2 -depen-
dent inactivation. At constant-free [Ca
2 ] (i.e., in buffered standard solu-
tions), the apparent [Ca
2 ] gradually decays exponentially over time. At
640 nM of free [Ca
2 ], the decay had a time constant     95   4 min
(mean r
2   0.97). The traces shown are not adjusted for aequorin inactiva-
tion.
Microscopy
Images were obtained on a microscope (model BX51/61; Olympus) with a
Hg arc lamp, a 60  1.4 NA Plan Apochromat objective, and a camera
(model Sensicam QE; Cooke). The camera and microscope are controlled
by IP Lab (Scanalytics). Vacuole sizes were measured by photographing
wet mounts of reactions containing 2  M MDY-64, a fluorescent lipid
probe (Molecular Probes). Vacuoles were measured using Image/J (http://
rsb.info.nih.gov/ij/) by manually circumscribing vacuoles with best-fit el-
lipses. The mean of the major and minor diameters of each ellipse was
used to estimate vacuole surface area, by approximating vacuoles as
spheres of radius diam/2. Surface areas were distributed approximately log
normally, so these data were log transformed before statistical analysis (in
JMP 5; SAS Institute) and geometric means were reported.
Online supplemental material
Video 1. Video microscopy of fusion occurring after rVam7p rescue of an
anti-Sec17p block. Video microscopy images were acquired with a 60 
1.4 NA Plan Apochromat objective and a camera (model Sensicam QE;
Cooke) mounted on a hybrid BX51/61 platform (Olympus). The camera
and microscope were controlled by IP Lab (Scanalytics) running under
Mac OS X. Illumination was provided by an Hg arc lamp (Olympus).
Time-lapse observations were made under illumination attenuated by
 98% using neutral density filters (Olympus) and an infrared-blocking fil-
ter (Schott), and data was acquired with 2   2 pixel binning. Images were
acquired at ambient temperature, measured at 23–25 C with a thermocou-
ple on the microscope stage. For time-lapse sequences a sharpening filterCa
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(5   5 hat) was applied to each frame. Online supplemental material is
available at htttp://www.jcb.org/cgi/content/full/jcb.200310105/DC1.
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